Braveheart Bio (BRVE) vs Korsana Biosciences (KRSA)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
Korsana Biosciences is the larger company by market cap ($1.71 billion vs $1.67 billion), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | BRVE | KRSA |
|---|---|---|
| Share price | $20.39 | $37.56 |
| Market cap | $1.67B | $1.71B |
| 1-day change | +5.81% | +5.95% |
| YTD return | — | +322.50% |
| 1-year return | — | +262.55% |
| 5-year return | — | -89.05% |
| EPS (TTM) | $-6.59 | $-16.14 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | — | $2.07M |
| Revenue growth (YoY) | — | +3.70% |
| Net income (latest FY) | — | $-3.53M |
| Operating margin | — | -239.78% |
| Net margin | — | -170.11% |
| 52-week high | $32.00 | $59.36 |
| 52-week low | $16.70 | $7.19 |
| Distance from 52-week high | -36.28% | -36.73% |
| Analyst consensus | strong_buy | strong_buy |
| Avg. price target upside | +123.15% | +17.15% |
| Average volume | 491.27K | 119.71K |
| Shares outstanding | 82.07M | 45.54M |
| Employees | 49 | 19 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Braveheart Bio
BRVE stock →Braveheart Bio, Inc. a clinical-stage biopharmaceutical company focused on developing therapies for patients with hypertrophic cardiomyopathy (HCM) and other serious cardiovascular diseases.
Health Care · Biotechnology: Pharmaceutical Preparations · 49 employees
About Korsana Biosciences
KRSA stock →Korsana Biosciences, Inc. develops therapeutic antibodies for the treatment of neurodegenerative diseases.
Health Care · Biotechnology: Pharmaceutical Preparations · 19 employees
BRVE vs KRSA FAQ
Which is bigger, Braveheart Bio or Korsana Biosciences?
Korsana Biosciences (KRSA) is larger, with a market capitalization of $1.71B compared with $1.67B for Braveheart Bio (BRVE).
Are Braveheart Bio and Korsana Biosciences in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.